导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.90% | 1486/4773 |
| 近一周 | -1.47% | 461/5462 |
| 近一月 | 0.62% | 526/5421 |
| 近一季 | -2.52% | 1258/5209 |
| 近半年 | -12.69% | 3791/4920 |
| 近一年 | 10.43% | 1004/4366 |
| 近两年 | 42.25% | 1777/2954 |
| 近三年 | 26.55% | 1201/2253 |
| 成立以来 | 79.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
8.89% 98/4961 |
-5.57% 3595/5312 |
- - |
- - |
| 2025 | 15.59% 2530/4813 |
-2.05% 2835/3635 |
1.49% 2310/4076 |
9.52% 3350/4524 |
6.17% 375/4813 |
| 2024 | 14.69% 1024/3463 |
7.03% 266/2808 |
1.06% 507/3014 |
9.39% 2704/3129 |
-3.07% 2253/3463 |
| 2023 | -0.48% 457/2656 |
12.25% 307/2280 |
0.74% 280/2385 |
-5.37% 1312/2515 |
-7.00% 2009/2655 |
| 2022 | -13.69% 338/2207 |
-7.96% 265/1919 |
4.21% 1035/2016 |
-11.76% 575/2113 |
1.98% 1070/2208 |
| 2021 | 12.98% 369/1822 |
4.36% 151/1255 |
4.22% 910/1330 |
5.42% 274/1466 |
-1.47% 1368/1822 |
| 2020 | 18.52% 741/1250 |
-5.01% 394/1028 |
0.23% 1007/1067 |
12.03% 409/1164 |
11.12% 563/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 富国中证国企一带一路ETF联接A VS. 长安沪深300非周期A(740101) |